New version of Usher Syndrome test

Asper Biotech has launched a new version of Usher syndrome test. The APEX-based test has been updated to include 810 alterations associated with different types of Usher syndrome, as well as nonsyndromic hearing loss and deafness.

For more comprehensive diagnostics we are also offering Usher syndrome Next-Gen Panel that covers the analysis of eleven disease-related genes – ABHD12, CDH23, CLRN1, DFNB31, HARS, GPR98, MYO7A, PCDH15, USH2A, USH1C, and USH1G.

For more information please view http://www.asperbio.com/asper-ophthalmics/usher-syndrome.